Innovation and the Pharmaceutical Industry : Critical Reflections on the Virtues of Profit.
Engelhardt, H. Tristram.
Innovation and the Pharmaceutical Industry : Critical Reflections on the Virtues of Profit. - 1st ed. - 1 online resource (253 pages)
Intro -- Contents -- Preface -- I. Introduction -- Pharmaceutical Innovation and the Market: The Pursuit of Profit and the Amelioration of the Human Condition -- II. The Social Responsibility of Pursuing Profit -- The Unavoidable Goodness of Profit: The Cunning of Reason and the Realization of Human Well-Being -- Corporate Social Responsibility and Business Ethics in the Pharmaceutical Industry -- Pharmaceutical Companies and Their Obligations to Developing Countries: Psychopaths or Scapegoats? -- III. Autonomy, Advertising, and Pharmaceutical Costs -- Autonomy, Constraining Options, and Pharmaceutical Costs -- Pharmaceutical Advertising and Patient Autonomy -- IV. Some Criticisms of the Pharmaceutical Industry Critically Re-examined -- Why America Does Not Have a Second Drug Problem -- Global Drug Innovation in a World of Financial Finitude: Retailing Virtue to Promote Capital Formation and Profit -- V. Markets, Pharmaceuticals, and Health Savings Accounts -- Time, Money and the Market for Drugs -- Perils of Parallel Trade: Reimporting Prescription Drugs from Canada to the US -- VI. Pharmaceutical Liability: Another Source of Health Care Costs -- Risk, Responsibility, and Litigation -- Contributors -- Index.
9780980209471
Pharmaceutical industry.
Drug development.
Medical innovations.
Medical policy -- United States.
Drugs -- economics -- United States.
Electronic books.
HD9665.5 -- .I55 2008eb
338.4/791510973
Innovation and the Pharmaceutical Industry : Critical Reflections on the Virtues of Profit. - 1st ed. - 1 online resource (253 pages)
Intro -- Contents -- Preface -- I. Introduction -- Pharmaceutical Innovation and the Market: The Pursuit of Profit and the Amelioration of the Human Condition -- II. The Social Responsibility of Pursuing Profit -- The Unavoidable Goodness of Profit: The Cunning of Reason and the Realization of Human Well-Being -- Corporate Social Responsibility and Business Ethics in the Pharmaceutical Industry -- Pharmaceutical Companies and Their Obligations to Developing Countries: Psychopaths or Scapegoats? -- III. Autonomy, Advertising, and Pharmaceutical Costs -- Autonomy, Constraining Options, and Pharmaceutical Costs -- Pharmaceutical Advertising and Patient Autonomy -- IV. Some Criticisms of the Pharmaceutical Industry Critically Re-examined -- Why America Does Not Have a Second Drug Problem -- Global Drug Innovation in a World of Financial Finitude: Retailing Virtue to Promote Capital Formation and Profit -- V. Markets, Pharmaceuticals, and Health Savings Accounts -- Time, Money and the Market for Drugs -- Perils of Parallel Trade: Reimporting Prescription Drugs from Canada to the US -- VI. Pharmaceutical Liability: Another Source of Health Care Costs -- Risk, Responsibility, and Litigation -- Contributors -- Index.
9780980209471
Pharmaceutical industry.
Drug development.
Medical innovations.
Medical policy -- United States.
Drugs -- economics -- United States.
Electronic books.
HD9665.5 -- .I55 2008eb
338.4/791510973